- Deciphera Pharmaceuticals (NASDAQ:DCPH) +121% on positive late-stage ripretinib data.
- DelMar Pharmaceuticals (NASDAQ:DMPI) +24% on offer of nearly 5M shares.
- Alcentra Capital (NASDAQ:ABDC) +20% on being acquired by Crescent Capital BDC.
- Avaya Holdings (NYSE:AVYA) +12% on strategic alternative talks.
- Genworth Financial (NYSE:GNW) +12% on extending merger pact.
- Village Farms International (NASDAQ:VFF) +12% on Q2 results.
- Yield10 Bioscience (NASDAQ:YTEN) +11% on Q2 results.
- DouYu International Holdings (NASDAQ:DOYU) +9% on Q2 results.
- Grupo Supervielle S.A. (NYSE:SUPV) +7% on Q2 results.
- JD.com (NASDAQ:JD) +6% on Q2 results.
- Eros International Plc (NYSE:EROS) +6%.
- Banco Macro S.A. (NYSE:BMA) +6%.